To metastasize, carcinoma cells must attenuate cell-cell adhesion to disseminate into distant organs. A group of transcription factors, including Twist1, Snail1, Snail2, ZEB1, and ZEB2, have been shown to induce epithelial mesenchymal transition (EMT), thus promoting tumor dissemination. However, it is unknown whether these transcription factors function independently or coordinately to activate the EMT program. Here we report that direct induction of Snail2 is essential for Twist1 to induce EMT. Snail2 knockdown completely blocks the ability of Twist1 to suppress E-cadherin transcription. Twist1 binds to an evolutionarily conserved E-box on the proximate Snail2 promoter to induce its transcription. Snail2 induction is essential for Twist1-induced cell invasion and distant metastasis in mice. In human breast tumors, the expression of Twist1 and Snail2 is highly correlated. Together, our results show that Twist1 needs to induce Snail2 to suppress the epithelial branch of the EMT program and that Twist1 and Snail2 act together to promote EMT and tumor metastasis. Cancer Res; 71(1); 245-54. Ó2011 AACR.
Introduction
For carcinoma cells to break away from neighboring cells and invade, they must lose cell-cell adhesion and gain motility (1) . A highly conserved developmental program named epithelial mesenchymal transition (EMT) has been implicated in promoting dissemination of single carcinoma cells from primary epithelial tumors (2) . The EMT program is activated during many developmental processes such as mesoderm formation and neural crest development (3) . During EMT, cells lose their epithelial characteristics, including cell adhesion and polarity, and acquire a mesenchymal morphology and the ability to migrate. Biochemically, cells switch off the expression of epithelial markers such as adherens junction protein E-cadherin and turn on mesenchymal markers including vimentin and fibronectin (4) .
Functional loss of E-cadherin in an epithelial cell has been considered a hallmark of EMT. Forced expression of E-cadherin in certain invasive carcinoma cells can inhibit their ability to invade and metastasize; conversely, blocking E-cadherin function in noninvasive tumor cells activates their invasiveness and metastatic abilities (5, 6) . A partial loss of E-cadherin is also associated with carcinoma progression and poor prognosis in various tumor types (7) .
Transcriptional modulation of the E-cadherin gene promoter is a key event to suppress E-cadherin expression during EMT. The human E-cadherin promoter contains E-box elements that are responsible for its transcriptional repression (8, 9) . Several Zn (zinc)-finger transcription factors, including Snail1 (10, 11) , Snail2 (12), ZEB1 (13) , and ZEB2 (14) , are capable of directly binding to the E-boxes of the E-cadherin promoter to repress its transcription. In addition to these Zn-finger transcription factors, transcription factors belonging to other families have also been shown to regulate EMT in culture and during development. In a search for genes involved in mouse mammary tumor metastasis, the bHLH transcription factor Twist1 is found to be capable of inducing EMT in human mammary epithelial cells. Our previous study also found that the Twist1 transcription factor was essential for the ability of tumor cells to metastasize from the mammary gland to the lung in a mouse breast tumor model (15) .
During EMT in metastasis and in embryogenesis, many EMT-inducing transcription factors, such as expression of Twist1, Snail1, Snail2, and ZEB2 in neural crest cells (16, 17) , are often activated simultaneously. To understand how these transcription factors coordinate the EMT program, we have used an inducible Twist1 system to address whether and how Twist1 activates other EMT-inducing transcription factors to suppress E-cadherin and promote EMT and tumor metastasis.
Materials and Methods

Cell lines
Human mammary epithelial (HMLE) cells were obtained from Dr. Robert Weinberg and cultured as described (18) . SUM1315 and MCF7 cells were obtained from the American Type Culture Collection and cultured as described (19) .
Antibodies
Primary antibodies used include Twist1 (20) , E-cadherin, b-catenin, g-catenin, fibronectin, vimentin, and N-cadherin (BD Biosciences); b-actin (Abcam), as previously described (15) 
Quantitative PCR
Total RNAs were extracted using RNeasy Mini Kit (Qiagen) and reverse transcribed using cDNA Reverse Transcription Kit (Applied Biosystems). Resulting cDNAs were analyzed in triplicates by using SYBR-Green PCR mix (Applied Biosystems). Relative mRNA concentrations were determined by 2
ÀC À
t Cc , where C t and C c are the mean threshold cycle differences after normalizing to GAPDH values. Primers used for PCR are listed in Supplementary Table 1 .
Immunofluorescence
Cells were grown on coverslip slides for 3 days, fixed with 4% paraformaldehyde (PFA), permeabilized with 0.1% Triton X-100 for 10 minutes, and blocked with 5% goat serum. Samples were incubated with primary and Alexa secondary antibodies (Invitrogen). After washing, wells were covered with SlowFade with 4 0 ,6-diamidino-2-phenylindole (DAPI; Invitrogen). Antibodies were used as described (15) .
ChIP sequencing
An Illumina sequencing library was prepared from Twist1 ChIP DNA obtained from induced HMLE-Twist1-ER cells using the ChIP-seq Sample Preparation Kit (Illumina). The DNA library was sequenced on the Illumina Genome Analyzer. The resulting sequence reads were mapped to the human genome by using the Illumina software suite. The data are displayed on the UCSC genome browser 2006 assembly.
Chromatin immunoprecipitation
Cells were cross-linked with 1% PFA, lysed, and sonicated. Nuclear lysates were incubated with Protein G Dynabeads (Invitrogen) conjugated with an anti-Twist1 or anti-estrogen receptor antibody overnight. DNA was reverse cross-linked and purified. Primers used for PCR are described in Supplementary Materials.
Luciferase reporter assay
MCF7 cells were transfected with Snail2prom-Luc2 reporter plasmid, pGL4[Rluc] plasmid, and additional plasmids as described. Twenty-four hours later, the cell lysates were assayed accordingly (Promega). The firefly luciferase activity was normalized to that of Renilla luciferase.
Promoter sequence alignment
Analysis of the Snail2 promoter E-box sequences across species was conducted using ConTra online software (23) .
Invasion and migration assays
A total of 40,000 cells were cultured on 8-mm Transwell (Costar) for 72 hours, fixed with 4% PFA, washed, and stained with 0.1% crystal violet. The top membrane was cleaned, washed, and dried. Crystal violet was released with 10% acetic acid, and the absorbance was measured at 520 nm. All assays were carried out in triplicates.
Subcutaneous tumor implantation and metastasis assay
A total of 1 million HMLER-Twist1 cells expressing shControl and 4 million HMLER-Twist1 cells expressing shSnail2 were injected subcutaneously into Nude mice. Tumor size was measured weekly until reaching 2 cm in diameter before mice were sacrificed. Lungs were imaged under a fluorescence dissection microscope.Thetotalnumberofgreenfluorescentprotein(GFP)-positive colonies was quantified using ImageJ. Graphed tumor weight represents total primary tumor burden per mouse.
Bioinformatics and statistical analysis
Three published microarray data sets were downloaded from the NCBI Gene Expression Omnibus (GEO). Obtained GEO identifiers (study name, sample size) were GSE1456 (STOCKHOLM, n ¼ 159), GSE2034 (EMC, n ¼ 286), and GSE3494 (UPPSALA, n ¼ 236). All samples were from breast cancer patients. Quantile normalization was conducted on an integrated data set of.CEL files (24) . The Median-Polish algorithm was used to convert multiple probe-level measurement values into the gene-level aggregate value (25) . The Spearman correlation coefficient was calculated between Twist1 and individual genes and ranked in individual data sets. Measurement values of the 2 probe sets were plotted in Supplementary  Figure 4 with a linear regression model fit.
Results
Twist1 indirectly suppresses E-cadherin transcription to promote EMT
To understand how Twist1 suppresses E-cadherin expression during EMT, we have generated a fusion protein between Twist1 and the modified hormone-binding domain of the estrogen receptor (Twist1-ER), which can be activated specifically upon binding to 4-hydroxytamoxifen (4-OHT; ref. 26 ). We expressed Twist1-ER in the immortalized HMLE cells via retroviral infection. HMLE cells expressing Twist1-ER underwent morphologic changes of EMT upon 4-OHT treatment in 10 to 12 days (Fig. 1A) . We harvested these cells at day 18 to characterize the EMT markers and found that activation of Twist1 resulted in the loss of cell adhesion and gain of mesenchymal differentiation in HMLE cells (Fig. 1B) , identical to the EMT program induced by Twist1 (15) .
We next examined the expression of E-cadherin mRNA and protein following Twist1 activation. Interestingly, both E-cadherin mRNA and protein levels remained unchanged during the first 7 days after Twist1 activation and only started decreasing afterward. By the end of the 12-day time course, both E-cadherin mRNA and protein decreased drastically ( Fig. 1C and D) , which correlated with the loss of cell adhesion in cell morphology (Fig. 1A) . Given that 4-OHT activates the Twist1-ER fusion protein immediately (26) , the 6 to 8 days required to reduce E-cadherin mRNA and protein levels suggest that Twist1 does not directly suppress E-cadherin transcription during EMT.
Induction of the transcription factor Snail2 is required for Twist1-induced EMT Because Twist1 may not directly suppress E-cadherin transcription, we hypothesized that Twist1 might activate other Zn-finger transcription factors such as Snail1, Snail2, ZEB1, and ZEB2 to suppress E-cadherin transcription. During Drosophila mesoderm formation, Twist1 directly induces the expression of Snail1 to promote EMT (27) . To test whether Twist1 induces the Snail family transcription factors in human cells, we examined Snail1 and Snail2 expression following Twist1 activation. Interestingly, Snail2 was induced within 4 hours upon Twist1 activation ( Fig. 2A) whereas Snail1 was only significantly induced at day 12 ( Supplementary Fig. 1 ). Induction of Snail2 protein was also observed in HMLETwist1-ER cells 2 days upon Twist1 activation and in HMLE cells expressing Twist1 (Fig. 2B ). Since we are interested in possible direct target genes that Twist1 regulates to suppress E-cadherin, we hypothesized that induction of Snail2 by Twist1 could play a key role in the transcriptional repression of E-cadherin.
To test whether induction of Snail2 is required for the ability of Twist1 to induce EMT, we designed 2 shRNA lentiviral constructs specifically against human Snail2 promoter and expressed them in HMLE cells. Both shSnail2-1 and shSnail2-2 could efficiently suppress Snail2 mRNA and protein below the basal level in HMLE cells ( Fig. 2A-C) . We expressed both shRNAs against Snail2 in HMLE cells expressing the inducible Twist1-ER construct and treated the cells with 4-OHT. Interestingly, in the absence of Snail2, Twist1 could not induce the morphologic changes associated with EMT as observed in HMLE cells expressing a control shRNA construct. Instead, these cells with shSnail2 constructs maintained an epithelial morphology with intact cell-cell adhesions and a cobblestone-like morphology even after 18 days (Fig. 2D) . Also, knockdown of Snail2 did not affect Twist1 expression in these cells (Fig. 2B) . Together, these data indicate that induction of Snail2 is required for the ability of Twist1 to promote EMT in HMLE cells.
Induction of Snail2 is specifically responsible for the suppression of E-cadherin in response to Twist1 activation
To determine how suppression of Snail2 affects the expression of various EMT markers, we closely followed the entire time course of Twist1 activation in HMLE-Twist1-ER cells expressing shSnail2 or a control shRNA. First, we examined the expression of E-cadherin following the induction time course, as Snail2 is a direct repressor of E-cadherin (12) . Indeed, suppression of Snail2 in HMLE-Twist1-ER cells completely inhibited the progressive reduction of E-cadherin mRNA and protein upon 4-OHT treatment ( Fig. 3A and B) . In HMLE-Twist1-ER cells expressing a control shRNA, Ecadherin expression started decreasing at day 7 after Twist1 activation; at day 18, E-cadherin protein was completely lost and b-catenin disappeared from cell membranes, indicating the loss of adherens junctions upon Twist1 activation (Fig. 3C ). In contrast, in HMLE-Twist1-ER cells expressing shSnail2, both E-cadherin and b-catenin remained at cell-cell junctions even after 18 days of Twist1 activation (Fig. 3C) . These results indicate that Snail2 is critical for the ability of Twist1 to suppress E-cadherin and induce EMT. To understand whether suppression of E-cadherin by Snail2 is the only effect of Snail2 on the entire EMT program, we examined the mRNA and protein expression of EMT mesenchymal markers in response to Twist1 activation. Interestingly, we found that unlike E-cadherin, the initial induction of other EMT markers, including fibronectin, vimentin, and N-cadherin, occurred normally in the absence of Snail2 in HMLETwist1-ER cells upon 4-OHT treatment (Fig. 4A) . However, at day 7 when E-cadherin was not suppressed in HMLE-Twist1-ER cells expressing shSnail2, fibronectin, vimentin, and Ncadherin proteins failed to increase further to reach the high levels of induction observed in HMLE-Twist1-ER cells expressing a control shRNA (Fig. 4A and B) . We also conducted immunofluorescence analysis to examine the expression and localization of these EMT markers and observed similar effects ( Supplementary Fig. 2 ). In addition, we attempted to overexpress Snail2 in HMLE cells and found that Snail2 alone was not sufficient to induce EMT in HMLE cells (data not shown). These results suggest that, although Snail2 is not directly responsible for the induction of fibronectin, vimentin, and N-cadherin during EMT, the loss of Snail2 and E-cadherin suppression completely blocks EMT morphogenesis and attenuates the expression of mesenchymal markers, including fibronectin, vimentin, and N-cadherin.
Snail2 is a conserved direct transcriptional target of Twist1 in amniotes
Because Snail2 is induced immediately upon Twist1 activation and plays a critical role in Twist1-induced EMT, we tested whether Twist1 directly binds to the Snail2 gene promoter to activate its transcription. Using chromatin immunoprecipitation (ChIP) coupled with high-throughput sequencing, we identified a distinct Twist1-binding E-box domain 306 base pair (bp) from the transcription start site of the human Snail2 promoter (Fig. 5A) . In contrast, there is no significant enrichment for the 10-kb promoter regions of Snail1 or E-cadherin (Fig. 5A) . To show that Twist1 specifically binds to the Snail2 promoter, we treated HMLETwist1-ER cells with 4-OHT for 4 days and conducted ChIP analysis to pull-down Twist1-binding DNA fragments. Both Twist1 and ER antibodies could specifically enrich the E-box region of the human Snail2 promoter, whereas there was no specific enrichment for the control GAPDH gene (Fig. 5B) . To test the specificity of the Twist1-binding E-box on the Snail2 promoter, we tested the ability of Twist1 to activate the isolated 606-bp human Snail2 promoter by luciferase reporter assay. We found that Twist1 could activate the Snail2 promoter-driven luciferase activity and mutation of the Ebox sequence on the Snail2 promoter reduced Twist1-reduced activation (Fig. 5C ). These data suggest that Twist1 specifically and directly binds to the E-box on the human Snail2 promoter to activate its transcription. To test whether the direct regulation of Snail2 by Twist1 is conserved throughout evolution, we searched for the consensus Twist1-binding E-box and its surrounding sequence on the human Snail2 promoter across species. Interestingly, we found that this consensus Twist1-binding sequence (ccaCAtcTGgaagcc) on the Snail2 promoter is highly conserved among amniote genomes examined, including chimpanzee, monkey, mice, rabbit, armadillo, elephant, hedgehog, and chick (Fig. 5D) . However, this sequence could not be found in Xenopus and zebrafish, indicating that the direct induction of Snail2 by Twist1 is highly conserved in amniotes.
Induction of Snail2 is required for the ability of Twist1 to promote invasion and metastasis
Given that induction of Snail2 is required for activating the EMT program by Twist1, we next tested whether Snail2 plays an essential role in Twist1-mediated tumor cell invasion and metastasis. As in HMLE-Twist1-ER cells, knockdown of Snail2 also prevented constitutive Twist1-induced EMT in HMLE cells (Fig. 6A) . We tested whether Snail2 is required for Twist1-induced cell migration and invasion. As shown in Figure 6B , suppression of Snail2 resulted in reduced cell migration and invasion. These data indicate that cell migration and invasion induced by Twist1 require the activation of the entire EMT program. Without Snail2, Twist1 is not sufficient to promote cell migration and invasion.
We next tested whether Snail2 is required for the ability of Twist1 to promote tumor metastasis in vivo. To assess the role of Snail2 in tumor metastasis, we transformed GFP-labeled HMLE-Twist1 cells expressing shSnail2 or a control shRNA with oncogenic Ras (HMLER cells; Fig. 6A ). When we implanted these cells subcutaneously in nude mice, HMLER-Twist1 cells expressing a control shRNA generated hundreds of tiny GFP þ micrometastatic lesions in the lung (Fig. 6C) . Interestingly, when Snail2 was knocked down, HMLER-Twist1 cells failed to form GFP þ metastatic lesions in the lung (Fig. 6C) , even though the primary tumors reached similar weight as shControl tumors (Fig. 6D) . It is worth noting that knocked down Snail2 reduced the initial primary tumor seeding rates, probably due to the difficulty encountered by epithelial cells to establish cell-cell adhesion after being injected subcutaneously in suspension. Therefore, we allowed the Snail2 knockdown tumors to grow 4 more weeks in mice to reach the same primary tumor size as the control tumors ( Supplementary Fig. 3 ). Even with longer primary tumor growth time and similar final primary tumor burdens, examination of individual lung lobes revealed that the suppression of Snail2 caused a 500-fold reduction in the ability of HMLERTwist1 cells to form micrometastasis in the lung (Fig. 6D ).
Immunohistochemical analysis of the resulting tumors showed that E-cadherin expression was completely absent from cell membranes in HMLE-Twist1 tumors whereas suppression of Snail2 resulted in epithelial tumors with strong Ecadherin expression at cell-cell junctions (Fig. 6C) . Together, these results show that the activation of Twist1 is sufficient, at least in some cell types, to promote tumor cells to disseminate from the primary site to distant organs. Furthermore, the data strongly indicate that Snail2 functions downstream of Twist1 to play a critical role in regulating tumor invasion and metastasis.
Twist1 and Snail2 are frequently coexpressed in human breast tumors
To further show that a direct link between Twist1 and Snail2 exists in human tumor cells, we expressed shRNAs against Twist1 in the human breast tumor cell line SUM1315 that expresses high levels of endogenous Twist1 and Snail2. Indeed, when we examined the expression of endogenous Snail2 in these cells, we observed a dramatic reduction in Snail2 expression upon suppression of Twist1 (Fig. 7A) . This result indicates that the expression of endogenous Snail2 is dependent on Twist1 in human breast tumor cells.
To more directly probe the association between Twist1 and Snail2 in human breast tumor samples, we analyzed 3 published human breast tumor gene expression data sets summing up to 681 primary breast cancers (28) (29) (30) . In each data set, we ranked all 22,282 genes on the basis of how tight their expression levels are correlated with Twist1 in individual samples. As shown in Figure 7B , in all 3 data sets, Snail2 was consistently ranked as one of the most correlated genes with Twist1. Furthermore, expression of Twist1 and Snail2 was positively correlated (Supplementary Fig. 4) . The association between Twist1 and Snail2 in human breast tumor samples provides further support for a functional link between Twist1 and Snail2 in breast tumor progression.
Discussion
Our study has identified Snail2 as the direct transcription target of Twist1 in repressing E-cadherin during the EMT program. We show that induction of Snail2 is required for the ability of Twist1 to promote EMT in culture and distant metastasis in mice. Furthermore, we identified a conserved Twist1-binding site on the proximate Snail2 promoter in amniotes. These results show that Twist1 induces Snail2 to coordinate the EMT program to promote tumor metastasis (Fig. 7C) .
Our study revealed an evolutionally conserved link between Twist1 and its direct transcription target Snail2 in suppressing E-cadherin transcription, thus promoting the loss of cell adhesion during EMT. In Drosophila, Twist1 directly induces Snail1 to promote EMT during mesoderm formation (27) . Our study shows that in humans, Snail2, a family member, replaces Snail1 to carry out this key function downstream of Twist1 during EMT. Elevated expression of both Twist1 and Snail2 has been observed in lymph node-positive breast tumors and associated with poor outcome (31). Twist1 and Snail2 are also functionally linked during early embryogenesis. In early Xenopus embryo, loss of Twist1 leads to a decrease in the Snail2 mRNA level, and both of them negatively regulate the expression of Cerberus, an inhibitor of Nodal, BMP, and Wnt signaling (32) . During Xenopus embryonic vasculogenesis, Research.
on April 13, 2017. © 2011 American Association for Cancer cancerres.aacrjournals.org Downloaded from knockdown of Twist1 or Snail2 provoked similar embryonic hemorrhage and either Twist1 or Snail2 could rescue the hemorrhage defects due to Myc knockdown (33) . Together, these date show that the direct link between Twist1 and Snail2 is highly conserved and functionally important during embryogenesis and tumor metastasis.
Interestingly, induction of Snail2 is not only required for the ability of Twist1 to suppress E-cadherin but also the entire EMT morphogenesis is blocked in the absence of Snail2. Further analyses of additional EMT markers following the time course of Twist1 activation indicate that genes such as Ncadherin can initially increase at similar rates in the absence of Snail2. The initial immediate induction of N-cadherin is possibly due to the direct action of Twist1, together with its dimerization partner E12/E47. Interestingly, N-cadherin failed to further increase to the high induction level after 7 days of Twist1 activation, the exact time when E-cadherin is supposed to be suppressed upon Twist1 activation. This result indicates that although Snail2 is not directly responsible for the induction of N-cadherin, induction of Snail2 and suppression of E-cadherin are essential to send out a permissive signal to allow further expression of mesenchymal markers and the progression of the EMT program.
The permissive signal that allows progression of the EMT program remains unknown. The disappearance of E-cadherin from adherens junctions results in the release of its partner, b-catenin, into the cytosol, which has the potential to enter the nucleus to activate LEF/TCF (T-cell factor/lymphoid enhancer factor)-mediated transcription. Although the contribution of the adherens junction-associated b-catenin pool to transcription is still a matter of debate, several studies suggest that b-catenin-mediated transcription can further induce the expression of Snail2 (34) and Twist1 (35) , thereby contributing to the EMT program. Furthermore, fibronectin and vimentin have been shown to be b-catenin target genes (36) (37) (38) , which explains why suppression of Snail2 expression blocks their further induction in response to Twist1 activation. Similarly, ZEB2 has also been shown to not only suppress E-cadherin but also to partially regulate vimentin expression (39) . Together, these studies suggest that suppression of E-cadherin not only breaks the physical barrier to allow cell scattering but also could actively contribute to the activation of mesenchymal traits during EMT.
We found that Snail2 was induced 4 hours after Twist1 activation; however, reduction of E-cadherin mRNA became significant only 7 days after Twist1 activation. This observation raises the question of whether Snail2 alone is sufficient to suppress E-cadherin transcription during Twist1-induced EMT. Several observations could help to explain this phenomenon. First, we found that 2 additional E-cadherin-suppressing Chromatin was immunoprecipitated using corresponding antibodies and PCR was conducted using 1 primer set for the Twist1-binding region on the Snail2 promoter and 1 control set for GAPDH. C, the 606-bp Snail2 promoter or the Snail2 promoter with E-box mutation were transfected with or without Twist1 and its dimerization partner E47 and processed for luciferase promoter assay. D, alignment of the conserved Twist1-binding E-box (bold) in Snail2 promoters. The number at the start of the sequence indicates the distance from transcription start sites. transcription factors, ZEB1 and ZEB2, were also induced upon Twist1 activation and suppression of Snail2 drastically inhibited induction of ZEB1 and ZEB2 upon Twist1 activation. Therefore, induction of ZEB1 and ZEB2 could be required to collaborate with Snail2 to achieve drastic suppression of Ecadherin transcription. A double-negative feedback loop controlling ZEB1/ZEB2 and microRNA-200 family expression could further promote the expression of ZEB1 and ZEB2 during EMT (40) (41) (42) (43) 
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